Viewing Study NCT00072358

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:10 AM
Ignite Modification Date: 2026-02-03 @ 4:31 AM
Study NCT ID: NCT00072358
Status: COMPLETED
Last Update Posted: 2022-05-16
First Post: 2003-11-04
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Monoclonal Antibody 3F8 and Sargramostim in Treating Patients With Neuroblastoma
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Neuroblastoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None disseminated neuroblastoma View
None localized unresectable neuroblastoma View
None recurrent neuroblastoma View
None regional neuroblastoma View
None stage 4S neuroblastoma View